152 related articles for article (PubMed ID: 38340685)
41. Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer.
Haque W; Verma V; Adeberg S; Rustomily R; Lo S; Butler EB; Teh BS
Rep Pract Oncol Radiother; 2021; 26(3):341-351. PubMed ID: 34277087
[TBL] [Abstract][Full Text] [Related]
42. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Kalkanis SN
J Neurooncol; 2010 Jan; 96(1):45-68. PubMed ID: 19960227
[TBL] [Abstract][Full Text] [Related]
43. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
Jensen CA; Chan MD; McCoy TP; Bourland JD; deGuzman AF; Ellis TL; Ekstrand KE; McMullen KP; Munley MT; Shaw EG; Urbanic JJ; Tatter SB
J Neurosurg; 2011 Jun; 114(6):1585-91. PubMed ID: 21166567
[TBL] [Abstract][Full Text] [Related]
44. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.
Tsao M; Xu W; Sahgal A
Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683
[TBL] [Abstract][Full Text] [Related]
45. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD; Klamer BG; Ballman KV; Brown PD; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
JAMA Oncol; 2022 Dec; 8(12):1809-1815. PubMed ID: 36264568
[TBL] [Abstract][Full Text] [Related]
46. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
[TBL] [Abstract][Full Text] [Related]
47. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
Neurosurgery; 2008 Feb; 62 Suppl 2():790-801. PubMed ID: 18596426
[TBL] [Abstract][Full Text] [Related]
49. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
50. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
Rades D; Kueter JD; Hornung D; Veninga T; Hanssens P; Schild SE; Dunst J
Strahlenther Onkol; 2008 Dec; 184(12):655-62. PubMed ID: 19107346
[TBL] [Abstract][Full Text] [Related]
51. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
52. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
53. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
54. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
[TBL] [Abstract][Full Text] [Related]
55. Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
McTyre E; Ayala-Peacock D; Contessa J; Corso C; Chiang V; Chung C; Fiveash J; Ahluwalia M; Kotecha R; Chao S; Attia A; Henson A; Hepel J; Braunstein S; Chan M
Ann Oncol; 2018 Feb; 29(2):497-503. PubMed ID: 29161348
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
57. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006121. PubMed ID: 22972090
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
[TBL] [Abstract][Full Text] [Related]
59. Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases.
Gorovets D; Rava P; Ebner DK; Tybor DJ; Cielo D; Puthawala Y; Kinsella TJ; DiPetrillo TA; Wazer DE; Hepel JT
Front Oncol; 2015; 5():110. PubMed ID: 26029666
[TBL] [Abstract][Full Text] [Related]
60. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
